Loading organizations...
Loading organizations...
Cell therapy company developing treatments for incurable diseases.
Eyestem has raised $8.5M across 2 funding rounds.
Eyestem has raised $8.5M in total across 2 funding rounds.
Eyestem has raised $8.5M in total across 2 funding rounds.
Eyestem's investors include Prabhavati Agro Green Energies, Alkem, Barmenia Next Strategies, Fastspeed Vanijya, Jacesa Investments, NATCO Pharmaceuticals, Satprem Trust, Inderjit Kaur Arora, Biological E, NATCO, Anurag Bagaria, Karan Bagaria.
Eyestem has raised $8.5M across 2 funding rounds. Most recently, it raised $2.1M Series B in October 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 8, 2025 | $2.1M Series B | Prabhavati Agro Green Energies | Alkem, Barmenia Next Strategies, Fastspeed Vanijya, Jacesa Investments, NATCO Pharmaceuticals, Satprem Trust, Inderjit Kaur Arora |
| Aug 8, 2022 | $6.4M Series A | Alkem, Biological E, NATCO | Anurag Bagaria, Karan Bagaria, Dr. Ramesh Byrapaneni, Kotak Private Equity |